For now, Philadelphians can take some comfort in knowing that, at least in the startup sphere, the City of Brotherly Love remains leagues ahead of Kansas City. In particular, the city and its environs boast a booming biotech scene that has long attracted hefty venture funding. (However, some of the actual Chiefs players are also players in the venture world.) A scan of the biggest Philly-area funding rounds of the past two years shows that, once again, life sciences and health reigns supreme, per Crunchbase data. The biggest standout for 2024 was Uniquity Bio, a developer of therapeutics based on advances in immunology that raised $300 million from Blackstone Life Sciences in May. In recent months, startup funding has continued to show Eagles-like momentum, including some pretty large rounds. This includes XyloCor Therapeutics, a startup focused on gene therapy for cardiovascular disease that secured $67.5 million in a Series B early this year. The second-largest round went to...
learn more
